Skip to main content

Advertisement

SpringerLink
Log in

RETRACTED ARTICLE: Association between glutathione S-transferase M1 null variant and risk of bladder cancer in Chinese Han population

  • Research Article
  • Published:
Tumor Biology

This article was retracted on 20 April 2017

Abstract

Glutathione S-transferase M1 (GSTM1) is one of the most important families of phase II isoenzymes known to detoxify a variety of electrophilic compounds and carcinogens. The GSTM1 null variant is associated with decreased enzyme activity, and it has been assumed to be associated with bladder cancer. The association between the GSTM1 null variant and bladder cancer in the Chinese Han population was unclear owing to the obvious inconsistency from published studies. To quantify the association between the GSTM1 null variant and bladder cancer in the Chinese Han population, we carried out the meta-analysis. We estimated the pooled odds ratio (OR) with its 95 % confidence interval (95 % CI) to assess the association. Eight studies with a total of 3,887 individuals were finally included into the meta-analysis. Overall, there was an obvious association between the GSTM1 null variant and risk of bladder cancer in the Chinese Han population (OR = 1.61, 95 % CI 1.41–1.84, P < 0.001). There was no heterogeneity across those eight studies (I 2 = 0 %). The cumulative meta-analyses showed a trend of more obvious association between the GSTM1 null variant and risk of bladder cancer in the Chinese Han population as data accumulated by year. There was no obvious evidence of publication bias in the meta-analysis. In conclusion, the GSTM1 null variant is significantly associated with risk of bladder cancer in the Chinese Han population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet. 2009;374:239–49.

    Article  CAS  PubMed  Google Scholar 

  2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29.

    Article  PubMed  Google Scholar 

  3. Mitra AP, Cote RJ. Molecular pathogenesis and diagnostics of bladder cancer. Annu Rev Pathol. 2009;4:251–85.

    Article  CAS  PubMed  Google Scholar 

  4. Jacobs BL, Lee CT, Montie JE. Bladder cancer in 2010: how far have we come? CA Cancer J Clin. 2010;60:244–72.

    Article  PubMed  Google Scholar 

  5. Schmitz-Drager BJ. Identifying risk factors in patients with non-muscle-invasive bladder cancer: clinical implications. Eur Urol. 2011;60:721–3.

    Article  PubMed  Google Scholar 

  6. Dong LM, Potter JD, White E, Ulrich CM, Cardon LR, Peters U. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA. 2008;299:2423–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Ye Y, Yang H, Grossman HB, Dinney C, Wu X, Gu J. Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer. Cancer. 2008;112:2467–74.

    Article  CAS  PubMed  Google Scholar 

  8. Sanyal S, Festa F, Sakano S, Zhang Z, Steineck G, Norming U, et al. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis. 2004;25:729–34.

    Article  CAS  PubMed  Google Scholar 

  9. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005;45:51–88.

    Article  CAS  PubMed  Google Scholar 

  10. Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology. 2000;61:154–66.

    Article  CAS  PubMed  Google Scholar 

  11. Srivastava DS, Mishra DK, Mandhani A, Mittal B, Kumar A, Mittal RD. Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer. Eur Urol. 2005;48:339–44.

    Article  CAS  PubMed  Google Scholar 

  12. Hao G, Xu C, Zhang H, Ge N, Meng Y, Yang M. GSTM1 genetic polymorphism and bladder cancer susceptibility [article in Chinese]. Chinese J Urol. 2002;23:344–6.

    Google Scholar 

  13. Ma QW, Lin GF, Chen JG, Shen JH. Polymorphism of glutathione S-transferase T1, M1 and P1 genes in a Shanghai population: patients with occupational or non-occupational bladder cancer. Biomed Environ Sci. 2002;15:253–60.

    PubMed  Google Scholar 

  14. Shao J, Gu M, Zhang Z, Xu Z, Hu Q, Qian L. Genetic variants of the cytochrome p450 and glutathione S-transferase associated with risk of bladder cancer in a south-eastern Chinese population. Int J Urol. 2008;15:216–21.

    Article  CAS  PubMed  Google Scholar 

  15. Song DK, Xing DL, Zhang LR, Li ZX, Liu J, Qiao BP. Association of NAT2, GSTM1, GSTT1, CYP2A6, AND CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China. Cancer Detect Prev. 2009;32:416–23.

    Article  CAS  PubMed  Google Scholar 

  16. Cash HL, Tao L, Yuan JM, Marsit CJ, Houseman EA, Xiang YB, et al. Line-1 hypomethylation is associated with bladder cancer risk among nonsmoking Chinese. Int J Cancer. 2012;130:1151–9.

    Article  CAS  PubMed  Google Scholar 

  17. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.

    Article  PubMed  PubMed Central  Google Scholar 

  18. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  CAS  PubMed  Google Scholar 

  19. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.

    CAS  PubMed  Google Scholar 

  20. Muellerleile P, Mullen B. Sufficiency and stability of evidence for public health interventions using cumulative meta-analysis. Am J Public Health. 2006;96:515–22.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Shao C, Xiang Y, Zhang W, Fang R, Cheng J. Polymorphisms of GSTM1 and GSTT1 with smoking and bladder cancer risk: a population-based case control study [article in Chinese]. Tumor. 2006;26:346–51.

    CAS  Google Scholar 

  23. Shao JF, Qian L, Wu H, Gu M, Hua L, Zhou J, et al. Genetic polymorphisms of GSTM1 and susceptibility to bladder cancer [article in Chinese]. Tumor. 2006;26:352–4.

    CAS  Google Scholar 

  24. Fu J, Yang Y, Chen B (2009) CYP1A1, NQO1, EPHX1 and GSTS gene polymorphism and bladder cancer susceptibility [article in Chinese]. Wanfang doctoral dissertation

  25. Wang Z, Xue L, Chong T, Li H, Chen H. Quantitative assessment of the association between glutathione S-transferase P1 Ile105Val polymorphism and bladder cancer risk. Tumour Biol. 2013;34:1651–7.

    Article  CAS  PubMed  Google Scholar 

  26. Zhang Y, Wang X, Zhang W, Gong S. An association between XPC Lys939Gln polymorphism and the risk of bladder cancer: a meta-analysis. Tumour Biol. 2013;34:973–82.

    Article  CAS  PubMed  Google Scholar 

  27. Simic T, Savic-Radojevic A, Pljesa-Ercegovac M, Matic M, Mimic-Oka J. Glutathione S-transferases in kidney and urinary bladder tumors. Nat Rev Urol. 2009;6:281–9.

    Article  CAS  PubMed  Google Scholar 

  28. Wang B, Huang G, Wang D, Li A, Xu Z, Dong R, et al. Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis. J Hepatol. 2010;53:508–18.

    Article  PubMed  Google Scholar 

  29. Zhu Y, He Q, Wang J, Pan HF. The association between GSTM1 polymorphism and gastric cancer risk: a meta-analysis. Mol Biol Rep. 2012;39:685–91.

    Article  CAS  PubMed  Google Scholar 

  30. Kumar V, Murthy AK, Suresh KP. Glutathione S-transferase M1 and T1 status and the risk of laryngeal cancer: a meta-analysis. Asian Pac J Cancer Prev. 2011;12:2221–6.

    PubMed  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Interventional Radiology, the Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China

    Wei Xu, Fa Wang, Li Ying & Hong-Hui Wang

Authors
  1. Wei Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fa Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Li Ying
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hong-Hui Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hong-Hui Wang.

Additional information

The Publisher and Editor retract this article in accordance with the recommendations of the Committee on Publication Ethics (COPE). After a thorough investigation we have strong reason to believe that the peer review process was compromised.

An erratum to this article can be found online at http://dx.doi.org/10.1007/s13277-017-5487-6.

About this article

Cite this article

Xu, W., Wang, F., Ying, L. et al. RETRACTED ARTICLE: Association between glutathione S-transferase M1 null variant and risk of bladder cancer in Chinese Han population. Tumor Biol. 35, 773–777 (2014). https://doi.org/10.1007/s13277-013-1105-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-1105-4

Keywords

Search

Navigation